1.
Devi WR, Prenggono MD, AP P, B I. Differences of Bone Marrow Features and BCR-ABL Variants in Chronic Granulocytic Leukemia Post Tyrosine Kinase Inhibitor Therapy. Indonesian J. Clin. Pathol. Med. Lab. [Internet]. 2020 Mar. 31 [cited 2024 May 17];26(2):217-22. Available from: https://www.indonesianjournalofclinicalpathology.org/index.php/patologi/article/view/1457